Eculizumab (Genetical Recombination) 300 ㎎ 30 mL/vial 81 vials,and 10 other contracts

2026-11-03

Official in charge of disbursement of the procuring entity : NAGAYASU Takeshi, President of Nagasaki University Classification of the products to be procured : Nature and quantity of the products to be purchased : A Eculizumab (Genetical Recombination) 30 ㎎ 3 mL/vial 8 vials B Ravulizumab (Genetical Recombination) 30 ㎎ mL/vial 1,03 vials C Inebilizumab (Genetical Recombination) vials/box boxes D Nusinersen Sodium 1 ㎎ mL/vial vials E Nusinersen Sodium 2 ㎎ mL/vial vials F Nusinersen Sodium 5 ㎎ mL/vial vials G Vutrisiran Sodium 1syringe/box boxes H Axicabtagene ciloleucel Once sets I Onasemnogene abeparvove Once box J Tisagenlecleucel Once set K TEMCELL 10. mL/bag 2 bags L Lisocabtagene maraleucel Once sets Delivery period : From April, 202 through 3 March, 202 Delivery place : Nagasaki University Hospital Qualifications for participating in the tendering procedures : Suppliers eligible for participating in the proposed tender are those who shall : A not come under Article and of the Regulation concerning the Contract for Nagasaki University. Furthermore, minors, Person under Conservatorshi or Person under Assistance may also be able to participate in a bid as long as they obtain the consent necessary for concluding a contract, B have the Grade A, Grade B or Grade C qualification during fiscal 202 in the Kyushu・Okinawa area in sales of product for participating in tenders by Single qualification for every ministry and agency, C prove to have obtained the first-class license for selling drugs in accordance with the Law on Securing Quality, Efficacy and Safety of Products including Pharmaceuticals and Medical Devices, D prove to have the ability to deliver the products, required by this notice, on the date and to the place specified by the Obligating Officer, E meet the qualification requirements which President of Nagasaki University may specify in accordance with Article of the Regulation, F not be currently under a suspension of business order as instructed by President of Nagasaki University. Time limit of tender : 1 : 0 1 March, 202 Contact point for the notice : KAWA-HARA Ryutaro, Accounting and Procurement Division, Nagasaki University Hospital, 1-7- Sakamoto Nagasaki-shi 852-850 Japan, TEL 095-819-775 ⑼ Please be noted that if it is indicated that environmental conditions relating to the procurement are laid down in its tender documents.

Japan

2026-03-26